Complete Power Range Consists of 10.0 to 33.0 Diopters
FOR RELEASE TUESDAY, JUNE 16, 2015
BRIDGEWATER, NJ — Bausch + Lomb, a leading global eye health company, today announces the TRULIGN® Toric intraocular lens (IOL) power range has expanded with the addition of 10.0-16.5 (in half diopter steps), providing eye care practitioners the full diopter range of the premium lens (from 10.0 to 33.0) for their cataract patients.
“Many of my patients with corneal astigmatism who undergo cataract surgery desire a broader range of vision for their everyday life,” said Jay Pepose, M.D., a cornea and refractive surgery specialist from St. Louis, MO. “The TRULIGN Toric IOL is available in a wide range of cylinder options, affording my patients both excellent distance and intermediate vision without glasses, so they can exercise, golf, work on a computer, drive a car and see the dashboard. The TRULIGN Toric IOL results in exceptional visual quality that my patients enjoy in all aspects of their lives. I’m pleased to have the lens available in extended powers to provide even more of my patients this novel lens technology.”
The TRULIGN Toric intraocular lens is the first and only toric IOL in the U.S. that corrects for astigmatism and has the additional capacity to deliver improved vision across a natural range of focus. When using a standard toric IOL, patients typically can only have focus for distance vision,1,2 however, with the aberration-free advanced optics featured in TRULIGN, patients are provided excellent visual acuity at intermediate and distance (UCIVA/UCDVA ≥20/40: 97.8% of eyes). Additionally, 99.2 percent of study participants who received the TRULIGN Toric IOL reported no visual disturbances on postoperative refraction following cataract surgery.3
The innovative TRULIGN Toric’s advanced aspheric optics provides excellent acuity and contrast for driving at night, minimizing halos and glare, as well as offering a uniform power, center to edge, for predictable results. Bausch + Lomb’sTRULIGN Toric also offers outstanding rotational stability3 (rotation ≤5o: 96.1 percent of eyes) and effective cylinder correction3 (residual cylinder ≤1.0 D: 95.5 percent of eyes).
For more information on the TRULIGN Toric, visit www.trulign.com.
About TRULIGN Toric
The TRULIGN Toric posterior chamber intraocular lens is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia and postoperative refractive astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire reduction of residual refractive cylinder with increased spectacle independence and improved uncorrected near, intermediate and distance vision.
About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We develop, manufacture and market one of the most comprehensive product portfolios in our industry with products available in more than 100 countries.
References
1. AcrySofIQ IOL, Product Information.
2. TECHNIS IOL Directions for Use.
3. TRULIGN® Toric Posterior Chamber Intraocular Lens Directions for Use. Bausch & Lomb Incorporated. May 2013.
TRULIGN is a trademark of Bausch & Lomb Incorporated or its affiliates.
© 2015 Bausch & Lomb Incorporated
# # #
News Media Contacts
Kristy Marks
PR Product Manager, Bausch + Lomb
(585) 338-8095 or kristy.marks@bausch.com
Tad Heitmann
BioComm Network on behalf of Bausch + Lomb
(714) 273-2937 or theitmann@BioCommNetwork.com
SUR/CRT/15/0097
United States
